Additional file 1 of Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers

Additional file 1: Table S1 List of eRNAs in 30 cancer types from TCGA. Table S2 Summary of characteristics of individuals in the replication stage. Table S3 Probes or primers sequence used in the study. Table S4 Summary of eRNAQTLs in 30 cancers. Table S5 Enrichment of eRNAQTLs in the histone modification peaks. Table S6 Enrichment of eRNAQTLs in the binding site of transcription factors. Table S7 Enrichment of eRNAQTLs in the binding site of RNA binding proteins. Table S8 Expression patterns of eRNAs in 30 cancers from TCGA. Table S9 Putative target genes of eRNAs in 30 cancers from TCGA. Table S10 Correlations between eRNAs and immune infiltration in 30 cancers from TCGA. Table S11 Correlations between eRNAs and drug response in 30 cancers from TCGA. Table S12 Correlations between eRNAs and patients’ survival in 30 cancers from TCGA. Table S13 Enhancers identified in our colorectal cancer tissues. Table S14 Enhancers identified in our adjacent normal tissues. Table S15 Enhancer RNAs identified in our colorectal cancer tissues. Table S16 Enhancer RNAs identified in our adjacent normal tissues. Table S17 eRNAQTLs identified in our colorectal cancer tissues. Table S18 eRNAQTLs identified in our adjacent normal tissues. Table S19 Tissue specificity of eRNAQTLs identified in our tissues.